Patent Assignment
Reel/Frame 065473/0327
Security Interest
Recorded: 2023-11-06
Pages: 13
Assignor
GATE NEUROSCIENCES, INC.
Executed: 2023-11-03
Assignee
INNOVIVA TRC HOLDINGS LLC
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CALIFORNIA, 94010
Covered Properties
(52)
Methods of Treating Depression and Other Related Diseases
Nmda Receptors Modulators and Uses Thereof
Secondary Structure Stabilized NMDA Receptor Modulators and Uses Thereof
Methods of Treating Depression and Other Related Diseases
Methods of Treating Depression and Other Related Diseases
Methods of Treating Depression and Other Related Diseases
Application:
13/937,979 →
Publication:
US 2013/0296248
Methods of Treating Depression and Other Related Diseases
Methods of Treating Depression and Other Related Diseases
Methods of Treating Alzheimer's Disease, Huntington's Disease, Autism, or Other Disorders
Application:
14/114,376 →
Publication:
US 2014/0107037
NMDA Receptor Modulators and Uses Thereof
Application:
14/162,328 →
Publication:
US 2015/0315237
Nmda Receptor Modulators and Uses Thereof
Application:
14/353,681 →
Publication:
US 2015/0051262
Methods of Treating Depression and Other Related Diseases
Application:
14/451,756 →
Publication:
US 2015/0182582
Methods of Treating Depression and Other Related Diseases
Secondary Structure Stabilized Nmda Receptor Modulators and Uses Thereof
Methods of Treating Alzheimer's Disease, Huntington's Disease, Autism, or Other Disorders
Application:
15/098,985 →
Publication:
US 2017/0049845
Methods of Treating Brain Disorders or Identifying Biomarkers Related Thereto
Application:
15/104,223 →
Publication:
US 2016/0345855
NMDA Receptor Modulators and Uses Thereof
Application:
15/252,132 →
Publication:
US 2016/0368947
Stable Compositions of Neuroactive Peptides
Application:
15/306,731 →
Publication:
US 2017/0049844
Methods of Treating Depression Using Nmda Modulators
Application:
15/503,840 →
Publication:
US 2017/0296616
Methods of Treating Depression and Other Related Diseases
Nmda Receptor Modulators and Uses Thereof
Application:
15/896,662 →
Publication:
US 2018/0237474
Ndma Receptor Modulators and Uses Thereof
Application:
16/028,664 →
Publication:
US 2019/0135862
Process for Synthesis of Peptide Compounds
Application:
16/074,307 →
Publication:
US 2021/0198315
Methods of Treating Alzheimer's Disease, Huntington's Disease, Autism, and Other Disorders
Application:
16/168,242 →
Publication:
US 2019/0209642
Methods of Administration of Nmda Receptor Agonists
Application:
16/185,522 →
Publication:
US 2019/0351006
Methods of Treating Depression and Other Related Diseases
Application:
16/188,869 →
Publication:
US 2019/0062372
Treatment with Nmda Receptor Modulators
Application:
16/210,056 →
Publication:
US 2020/0197365
Process and Intermediates for Synthesis of Peptide Compounds
Application:
16/634,719 →
Publication:
US 2020/0199173
Stable Compositions of Neuroactive Peptides
Application:
16/751,187 →
Publication:
US 2020/0254050
Treatment with Nmda Receptor Modulators
Application:
16/770,532 →
Publication:
US 2020/0368310
Methods of Treating Alzheimer's Disease, Huntington's Disease, Autism, and Other Disorders
Application:
16/867,324 →
Publication:
US 2021/0169964
Salt and Crystalline Forms of Rapastinel
Application:
17/421,915 →
Publication:
US 2022/0024976
Process and Intermediates for Synthesis of Peptide Compounds
Application:
17/558,190 →
Publication:
US 2022/0112239
Processes and Intermediates for Producing Diazaspiro Lactam Compounds
Solid Forms of Tert-Butyl (S)-2((2S,3R)-1-Amino-3-Hydroxy-1-Oxobu Tan-2-Yl)-1-Oxo-2, 5-Diazaspiro [3.4] Octan E-5-Carboxylate and Methods of Preparing Them
Application:
17/621,907 →
Publication:
US 2022/0267341
Treatment of Depression and Other Related Diseases
Application:
61/248,650 →
Secondary Structure Stabilized NMDA Receptor Modulators and Uses Thereof
Application:
61/303,472 →
Methods of Treating Alzheimer's Disease, Autism, or Related Disorders
Application:
61/479,593 →
Methods of Treating Alzheimer's Disease, Huntington's Disease, Autism, or Related Disorders
Application:
61/527,744 →
Nmda Receptor Modulators and Uses Thereof
Application:
61/550,782 →
Methods of Treating Brain Disorders or Identifying Biomarkers Related Thereto
Application:
61/915,835 →
Stable Compositions of Neuroactive Peptides
Application:
61/984,216 →
Methods of Treating or Ameliorating Migraine
Application:
62/015,727 →
Methods of Treating Depression Using Nmda Modulators
Application:
62/037,374 →
Methods of Treating or Ameliorating Migraine
Application:
62/109,386 →
Process for Synthesis of Peptide Compounds
Application:
62/289,655 →
Process and Intermediates for Synthesis of Peptide Compounds
Application:
62/538,117 →
Methods of Administration of Nmda Receptor Agonists
Application:
62/584,652 →
Treatment with Nmda Receptor Modulators
Application:
62/594,891 →
Salt and Crystalline Forms of Rapastinel
Application:
62/791,377 →
Solid Forms of Tert-Butyl (S)-2-((2S,3R)-1-Amino-3-Hydroxy-1-Oxobutan-2-Yl)-1-Oxo-2,5-Diazaspiro[3.4]Octane-5-Carboxylate and Methods of Preparing Them
Application:
62/865,826 →
Processes and Intermediates for Producing Diazaspiro Lactam Compounds
Application:
62/865,840 →
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 14, 2012
From: MOSKAL, JOSEPH
To: NORTHWESTERN UNIVERSITY
Reel/Frame 028199/0533 →
Assignment of Assignor's Interest
Aug 22, 2013
From: MOSKAL, JOSEPH
To: NORTHWESTERN UNIVERSITY
Reel/Frame 031062/0182 →
Assignment of Assignor's Interest
Jan 24, 2014
From: NAUREX, INC.
To: NORTHWESTERN UNIVERSITY
Reel/Frame 032039/0978 →
Assignment of Assignor's Interest
Jan 24, 2014
From: KHAN, AMIN; MOSKAL, JOSEPH
To: NAUREX, INC.
Reel/Frame 032039/0672 →
Assignment of Assignor's Interest
Jan 24, 2014
From: NAUREX, INC.
To: NORTHWESTERN UNIVERSITY
Reel/Frame 032039/0292 →
Assignment of Assignor's Interest
Jan 24, 2014
From: KHAN, AMIN; MOSKAL, JOSEPH
To: NAUREX, INC.
Reel/Frame 032039/0178 →
Assignment of Assignor's Interest
Oct 23, 2014
From: KHAN, M. AMIN; MOSKAL, JOSEPH
To: NORTHWESTERN UNIVERSITY
Reel/Frame 034021/0350 →
Assignment of Assignor's Interest
Nov 7, 2014
From: MOSKAL, JOSEPH; KHAN, AMIN
To: NAUREX, INC.
Reel/Frame 034128/0826 →
Assignment of Assignor's Interest
Nov 12, 2014
From: NAUREX, INC.
To: NORTHWESTERN UNIVERSITY
Reel/Frame 034156/0172 →
Confirmatory Assignment
Nov 18, 2014
From: MOSKAL, JOSEPH; KHAN, M. AMIN
To: NORTHWESTERN UNIVERSITY
Reel/Frame 034283/0684 →
Confirmatory Assignment
Nov 18, 2014
From: MOSKAL, JOSEPH; KHAN, M. AMIN
To: NORTHWESTERN UNIVERSITY
Reel/Frame 034283/0718 →
Assignment of Assignor's Interest
Mar 16, 2015
From: MOSKAL, JOSEPH R.
To: NORTHWESTERN UNIVERSITY
Reel/Frame 035170/0677 →
Assignment of Assignor's Interest
Jan 5, 2016
From: MOSKAL, JOSEPH R., MR.
To: NORTHWESTERN UNIVERSITY
Reel/Frame 037444/0583 →
Assignment of Assignor's Interest
Aug 23, 2016
From: MOSKAL, JOSEPH
To: NORTHWESTERN UNIVERSITY
Reel/Frame 039513/0951 →
Assignment of Assignor's Interest
Aug 24, 2016
From: MOSKAL, JOSEPH
To: NORTHWESTERN UNIVERSITY
Reel/Frame 039531/0432 →
Assignment of Assignor's Interest
Oct 31, 2016
From: MOSKAL, JOSEPH; KHAN, M. AMIN
To: NORTHWESTERN UNIVERSITY
Reel/Frame 040179/0388 →
Assignment of Assignor's Interest
May 4, 2017
From: ARGHAVANI, MOHSEN
To: NAUREX INC.
Reel/Frame 042242/0771 →
Assignment of Assignor's Interest
May 15, 2017
From: HOUCK, DAVID
To: NAUREX INC.
Reel/Frame 042375/0956 →
Security Interest
Dec 18, 2024
From: GATE NEUROSCIENCES, INC.
To: INNOVIVA TRC HOLDINGS LLC
Reel/Frame 069742/0846 →